B-Cell Malignant Neoplasm — Trials

B-Cell Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,083
Recruiting: 1,077
Ph III recruiting: 121
Growth YoY: +2.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,167)

clinicaltrialsPublishedShowing 601–650 of 887 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03060850	A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL	unknown	Phase 1	184	Hangzhou ACEA Pharmaceutical Research Co., Ltd.INDUSTRY	1	Feb 1, 2019	clinicaltrials
NCT03690310	Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma	unknown	Early Phase 1	9	Allife Medical Science and Technology Co., Ltd.INDUSTRY	0	Jan 31, 2019	clinicaltrials